Paraoxonase-1 and Simvastatin Treatment in Patients with Stable Coronary Artery Disease

Background. Paraoxonase-1 (PON1) is the crucial antioxidant marker of high-density lipoproteins. The present study is aimed at assessing the effect of simvastatin treatment on PON1 activity and its relationship to Q192R and M55L polymorphisms in subjects with stable coronary artery disease (CAD). Me...

Descripción completa

Detalles Bibliográficos
Autor principal: Januszek, Rafał
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860225/
https://www.ncbi.nlm.nih.gov/pubmed/27213056
http://dx.doi.org/10.1155/2016/6312478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860225/
https://www.ncbi.nlm.nih.gov/pubmed/27213056
http://dx.doi.org/10.1155/2016/6312478

Ejemplares similares